The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Martin Michael Robert since 2021.
This trader's CIK number is 1837647.
At the time of last reporting, Martin Michael Robert was the Chief Business Officer of Aurinia Pharmaceuticals Inc.. (stock ticker symbol AUPH).
Also see all insider trading activities at Aurinia Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | AUPH | 0 | $0 | 4,849 | $58,236 | 0 | $0 |
| 2021 | AUPH | 0 | $0 | 515,000 | $12,786,392 | 369,000 | $2,504,057 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-02 | AUPH | Sale | 4,849 | 12.01 | 58,236 |
| 2021-11-11 | AUPH | Option Ex | 29,000 | 18.38 | 533,020 |
| 2021-11-09 | AUPH | Sale | 50,000 | 30.17 | 1,508,500 |
| 2021-11-10 | AUPH | Sale | 60,000 | 30.91 | 1,854,300 |
| 2021-11-11 | AUPH | Sale | 40,000 | 29.16 | 1,166,400 |
| 2021-11-01 | AUPH | Option Ex | 45,000 | 3.20 | 144,000 |
| 2021-11-01 | AUPH | Sale | 45,000 | 31.64 | 1,423,800 |
| 2021-09-20 | AUPH | Option Ex | 28,500 | 5.30 | 151,050 |
| 2021-09-21 | AUPH | Option Ex | 87,500 | 9.91 | 867,387 |
| 2021-09-20 | AUPH | Sale | 28,500 | 21.66 | 617,167 |
| 2021-09-21 | AUPH | Sale | 87,500 | 24.02 | 2,101,750 |
| 2021-09-14 | AUPH | Option Ex | 44,000 | 5.30 | 233,200 |
| 2021-09-14 | AUPH | Sale | 44,000 | 21.77 | 957,660 |
| 2021-09-10 | AUPH | Sale | 25,000 | 19.80 | 495,000 |
| 2021-09-13 | AUPH | Option Ex | 25,000 | 5.30 | 132,500 |
| 2021-09-14 | AUPH | Option Ex | 90,000 | 4.25 | 382,500 |
| 2021-09-14 | AUPH | Sale | 90,000 | 21.19 | 1,907,190 |
| 2021-09-07 | AUPH | Sale | 7,500 | 18.10 | 135,750 |
| 2021-08-26 | AUPH | Sale | 22,500 | 17.81 | 400,725 |
| 2021-08-09 | AUPH | Sale | 5,000 | 16.01 | 80,050 |
| 2021-07-28 | AUPH | Sale | 5,000 | 13.86 | 69,300 |
| 2021-06-22 | AUPH | Sale | 5,000 | 13.76 | 68,800 |
| 2021-05-11 | AUPH | Option Ex | 20,000 | 3.02 | 60,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Martin Michael Robert (Chief Business Officer of Aurinia Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.